Obesity and left ventricular assist device driveline exit site infection.
about
Ventricular assist device implantation improves skeletal muscle function, oxidative capacity, and growth hormone/insulin-like growth factor-1 axis signaling in patients with advanced heart failureLeft ventricular assist device-related infections: past, present and future.The pharmacotherapy implications of ventricular assist device in the patient with end-stage heart failure.Impact of adverse events on ventricular assist device outcomes.Current concepts in the diagnosis and management of left ventricular assist device infections.Obesity in heart failure: impact on survival and treatment modalities.Interaction of obesity and infections.Effect of Body Mass Index on Outcomes in Left Ventricular Assist Device Recipients.Variability in infection control measures for the percutaneous lead among programs implanting long-term ventricular assist devices in the United States.Integrated home monitoring and compliance optimization for patients with mechanical circulatory support devices.Correlation between driveline features and driveline infection in left ventricular assist device selection.Readmission due to driveline infection can be predicted by new score by using serum albumin and body mass index during long-term left ventricular assist device support.Left Ventricular Assist Device and Bariatric Surgery: A Bridge to Heart Transplant by Weight and Waiting Time Reduction.Five-year results of patients supported by HeartMate II: outcomes and adverse events.A multi-modal intervention in management of left ventricular assist device outpatients: dietary counselling, controlled exercise and psychosocial support.Obesity in patients with end-stage heart failure
P2860
Q34590981-D3E569B1-FC3D-430D-8E0D-744F3EBB895BQ37949423-FF59A116-C9E6-49C2-9382-1BC9DAEB0AFBQ37990893-8C9FDC5B-3070-42A8-8E73-BDC1CC7972C1Q38073665-379867F5-6609-4886-95CF-415864A11E5BQ38081496-E6D47CAE-414F-40C3-A863-1A357985B5BCQ38128922-466700D8-96D8-490C-8E05-7EB843222C8BQ38583848-C35D69B7-A6EA-4777-8B12-0512073BF102Q38726490-03F78A24-F8E7-4E44-8157-48A00F36C41DQ39513183-CE0B5432-774D-4BA5-8821-09EC8CE8734CQ39698071-3E0867A8-C065-498E-8344-1B062F40D783Q40603345-16E95F2E-8D6C-4EB1-B29E-C2FC00197986Q41532622-9E32974C-5A09-4017-8D81-248ADC8115EEQ47334173-26048EFF-2166-4B84-9DE6-DA4517F9F7AAQ47622185-4148E326-2F2A-4F1C-8C2F-4973E76A2DCBQ48425218-316EDFE2-5BDB-46E1-B25B-8E1F8DAF971BQ57494737-A306A5A0-C891-4DE7-B8E3-BADE80F8C4A8
P2860
Obesity and left ventricular assist device driveline exit site infection.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Obesity and left ventricular assist device driveline exit site infection.
@en
Obesity and left ventricular assist device driveline exit site infection.
@nl
type
label
Obesity and left ventricular assist device driveline exit site infection.
@en
Obesity and left ventricular assist device driveline exit site infection.
@nl
prefLabel
Obesity and left ventricular assist device driveline exit site infection.
@en
Obesity and left ventricular assist device driveline exit site infection.
@nl
P2093
P1433
P1476
Obesity and left ventricular assist device driveline exit site infection.
@en
P2093
Abdallah G Kfoury
Ashley L Raymond
Bruce B Reid
Corey J Bishop
Craig H Selzman
Cris G Cowley
Deborah Budge
Erin S Davis
Hildegard Smith
Kimberly M Goebel
P356
10.1097/MAT.0B013E3181C879B1
P577
2010-01-01T00:00:00Z